OBJECTIVES: To examine the relations between the use of nonaspirin, nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin and age-related change in multiple domains of cognitive function in community-dwelling individuals without dementia. DESIGN: Longitudinal, with measures obtained on one to 18 occasions over up to 45 years. SETTING: General community. PARTICIPANTS: A volunteer sample of up to 2,300 participants from the Baltimore Longitudinal Study of Aging free of diagnosed dementia. MEASUREMENTS: At each visit, reported NSAID or aspirin use (yes/no) and tests of verbal and visual memory, attention, perceptuo-motor speed, confrontation naming, executive function, and mental status. RESULTS: Mixed-effects regression models revealed that NSAID use was associated with less prospective decline on the Blessed Information-Memory-Concentration (I-M-C) Test, a mental status test weighted for memory and concentration (P<.001), and Part B of the Trail Making Test, a test of perceptuo-motor speed and mental flexibility (P<.05). In contrast, aspirin use was related to greater prospective decline on the Blessed I-M-C Test (P<.05) and the Benton Visual Retention Test, a test of visual memory (P<.001). CONCLUSION: Consistent with studies of incident dementia, NSAID users without dementia displayed less prospective decline in cognitive function, but on only two cognitive measures. In contrast, aspirin use was associated with greater prospective cognitive decline on select measures, potentially reflecting its common use for vascular disease prophylaxis. Effect sizes were small, calling into question clinical significance, although overall public health significance may be meaningful.
OBJECTIVES: To examine the relations between the use of nonaspirin, nonsteroidal anti-inflammatory drugs (NSAIDs) and aspirin and age-related change in multiple domains of cognitive function in community-dwelling individuals without dementia. DESIGN: Longitudinal, with measures obtained on one to 18 occasions over up to 45 years. SETTING: General community. PARTICIPANTS: A volunteer sample of up to 2,300 participants from the Baltimore Longitudinal Study of Aging free of diagnosed dementia. MEASUREMENTS: At each visit, reported NSAID or aspirin use (yes/no) and tests of verbal and visual memory, attention, perceptuo-motor speed, confrontation naming, executive function, and mental status. RESULTS: Mixed-effects regression models revealed that NSAID use was associated with less prospective decline on the Blessed Information-Memory-Concentration (I-M-C) Test, a mental status test weighted for memory and concentration (P<.001), and Part B of the Trail Making Test, a test of perceptuo-motor speed and mental flexibility (P<.05). In contrast, aspirin use was related to greater prospective decline on the Blessed I-M-C Test (P<.05) and the Benton Visual Retention Test, a test of visual memory (P<.001). CONCLUSION: Consistent with studies of incident dementia, NSAID users without dementia displayed less prospective decline in cognitive function, but on only two cognitive measures. In contrast, aspirin use was associated with greater prospective cognitive decline on select measures, potentially reflecting its common use for vascular disease prophylaxis. Effect sizes were small, calling into question clinical significance, although overall public health significance may be meaningful.
Authors: C H Kawas; M M Corrada; R Brookmeyer; A Morrison; S M Resnick; A B Zonderman; D Arenberg Journal: Neurology Date: 2003-04-08 Impact factor: 9.910
Authors: K M Hayden; P P Zandi; A S Khachaturian; C A Szekely; M Fotuhi; M C Norton; J T Tschanz; C F Pieper; C Corcoran; C G Lyketsos; J C S Breitner; K A Welsh-Bohmer Journal: Neurology Date: 2007-07-17 Impact factor: 9.910
Authors: Stefano Tarantini; Peter Hertelendy; Zsuzsanna Tucsek; M Noa Valcarcel-Ares; Nataliya Smith; Akos Menyhart; Eszter Farkas; Erik L Hodges; Rheal Towner; Ferenc Deak; William E Sonntag; Anna Csiszar; Zoltan Ungvari; Peter Toth Journal: J Cereb Blood Flow Metab Date: 2015-07-15 Impact factor: 6.200
Authors: Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri Journal: Stroke Date: 2011-07-21 Impact factor: 7.914
Authors: Ariela R Orkaby; Rachel Ward; Jiaying Chen; Akshay Shanbhag; Howard D Sesso; J Michael Gaziano; Luc Djousse; Jane A Driver Journal: J Gerontol A Biol Sci Med Sci Date: 2022-05-05 Impact factor: 6.591
Authors: Stefano Tarantini; Andriy Yabluchanksiy; Gábor A Fülöp; Peter Hertelendy; M Noa Valcarcel-Ares; Tamas Kiss; Jonathan M Bagwell; Daniel O'Connor; Eszter Farkas; Farzaneh Sorond; Anna Csiszar; Zoltan Ungvari Journal: Geroscience Date: 2017-12-14 Impact factor: 7.713
Authors: Amy H Moore; Matthew J Bigbee; Grace E Boynton; Colin M Wakeham; Hilary M Rosenheim; Christopher J Staral; James L Morrissey; Amanda K Hund Journal: Pharmaceuticals (Basel) Date: 2010-06-02
Authors: Shwetha S Sequeira; Laura H P Eggermont; Rebecca A Silliman; Timothy W Bickmore; Lori E Henault; Michael R Winter; Kerrie Nelson; Michael K Paasche-Orlow Journal: J Health Commun Date: 2013